Ameneh Khatami - Concepedia

Author

Ameneh Khatami

Children's Hospital at Westmead ORCID

Also Known As

A Khatami, A. Khatami, Ameneh Khatami, Malmivaara K.

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Children's Hospital at Westmead The University of Sydney University of Oxford Westmead Institute for Medical Research Oxford BioMedica (United Kingdom)

About

Ameneh Khatami is an author at Children's Hospital at Westmead specializing in medicine, infection control, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	323
2	Public Health	4	4	89
3	Education	1	1	16
4	Health Sciences	1	1	16
5	African American Studies	1	1	16

Ameneh Khatami

Publications

Citations

H-Index

Page 1

	Year	Citations
Phage Therapy of <i>Mycobacterium</i> Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease Rebekah M. Dedrick, Bailey E. Smith, Madison Cristinziano, Clinical Infectious Diseases	2022	294
Sepsis-like Disease in Infants Due to Human Parechovirus Type 3 During an Outbreak in Australia Ameneh Khatami, Brendan McMullan, Murray Webber, Clinical Infectious Diseases	2014	118
Bacterial lysis, autophagy and innate immune responses during adjunctive phage therapy in a child Ameneh Khatami, Ruby C.Y. Lin, Aleksandra Petrović Fabijan, EMBO Molecular Medicine Host ResponsePathogenesisAutophagyImmunologyInnate Immune Responses	2021	66
Standardised treatment and monitoring protocol to assess safety and tolerability of bacteriophage therapy for adult and paediatric patients (STAMP study): protocol for an open-label, single-arm trial Ameneh Khatami, David A. Foley, Morgyn S. Warner, BMJ Open	2022	54
Parechovirus Genotype 3 Outbreak among Infants, New South Wales, Australia, 2013–2014 Germaine Cumming, Ameneh Khatami, Brendan McMullan, Emerging infectious diseases Virus EpidemiologyOctober 2013Disease OutbreakParechovirus Genotype 3Infectious Disease Control	2015	44
Refractory Pseudomonas aeruginosa infections treated with phage PASA16: A compassionate use case series Hadil Onallah, Ronen Hazan, Ran Nir‐Paz, Med AntibioticsBacteriophagePhage Pasa16MicrobiologyInfection Control	2023	43
High prevalence of developmental concern amongst infants at 12 months following hospitalised parechovirus infection Philip N Britton, Gulam Khandaker, Ameneh Khatami, Journal of Paediatrics and Child Health	2017	39
Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations Ameneh Khatami, Matthew D. Snape, Elizabeth G. Davis, Vaccine VaccinologyVaccinationCross-protectionVaccine DevelopmentAllergy	2012	31
Persistence of Immunity Following a Booster Dose of Haemophilus Influenzae Type B-Meningococcal Serogroup C Glycoconjugate Vaccine Ameneh Khatami, Matthew D. Snape, Tessa M. John, The Pediatric Infectious Disease Journal	2010	29
Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial David Pace, Ameneh Khatami, J McKenna, BMJ	2015	29

Page 1